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Available online 16 December 2009ORF50 protein activates the KSHV lytic cycle. The promoter of an early lytic-cycle gene ORF47, encoding
envelope protein gL, is activated by an interaction between ORF50 protein and RBP-Jκ. In ORF47p only one of
two sequences ﬁtting the consensus RBP-Jκ recognition site strongly binds RBP-Jκ and confers a response to
ORF50 protein. Flanking sequences 5′ to the RBP-Jκ binding site are required to confer a maximal response to
ORF50 protein. Not all mutant ORF50 response elements in the ORF47p that are bound by RBP-Jκ are
sufﬁcient to confer maximal ORF50 responsiveness. Four sequences containing an RBP-Jκ site and ﬂanking
sequences characteristic of the ORF50 response element in ORF47p were identiﬁed in human DNA. All bound
RBP-Jκ, but only one responded robustly to ORF50 protein. We propose models for the possible function of
ancillary sequences ﬂanking the RBP-Jκ-binding element which are crucial for mediating ORF50
transactivation.
© 2009 Elsevier Inc. All rights reserved.Introduction
Kaposi's sarcoma-associated herpesvirus (KSHV), human herpes-
virus 8, is implicated in the pathogenesis of Kaposi's sarcoma, primary
effusion lymphoma and multicentric Castleman's disease (Boshoff et
al., 1995; Cesarman et al., 1995; Chang et al., 1994; Soulier et al.,
1995). Based on similarities in nucleotide sequence, genome
organization, and biologic properties, KSHV is classiﬁed as a member
of the gamma subfamily of the Herpesviridae, which also includes the
transforming viruses Epstein-Barr virus (EBV) and Herpesvirus
saimiri (Chang et al., 1994; Russo et al., 1996). Like all herpesviruses,
KSHV has two distinct phases in its life cycle, latency and lytic
replication (Miller et al., 1997; Renne et al., 1996). Although the
physiological signals that stimulate the switch between latency- and
lytic-cycle gene expression of KSHV are not fully understood, chemical
agents such as 12-O-tetradecanoylphorbol-13-acetate or n-butyrate
signiﬁcantly disrupt viral latency and initiate the lytic cycle (Miller et
al., 1997). Upon chemical induction, the lytic cycle is expressed in a
temporally ordered program, which includes immediate-early,
delayed-early and late gene expression (Miller et al., 1997; Sun etLSOG, New Haven, CT 06520,
ll rights reserved.al., 1999). Among these viral genes, the immediate-early genes
encode regulatory proteins that up- and down-regulate the expres-
sion of viral and cellular genes and therefore play a crucial role in the
switch from latency to lytic replication (Zhu et al., 1999).
The protein encoded by open reading frame 50 (ORF50) of KSHV
genome is an immediate-early product that is sufﬁcient to trigger the
viral lytic cascade to completion in latently infected cells (Lukac et al.,
1999; Lukac et al., 1998; Sun et al., 1998). ORF50 protein is a potent
transcriptional activator that contains an N-terminal basic DNA-
binding domain and a C-terminal acidic activation domain (Chang and
Miller, 2004; Chang et al., 2002; Lukac et al., 1999; Wang et al., 2001).
Transient transfection experiments have demonstrated that ORF50
protein activates the promoters of a number of viral genes that are
expressed during the early stage of lytic cycle, including its own gene,
polyadenylated nuclear (PAN) RNA, K12 (kaposin), ORF57, K8, K9
(vIRF), ORF21 (thymidine kinase), K5, K6 (vMIP-1), ORF6 (single-
stranded DNA-binding protein), K14 (vOX-2), ORF74 (vGPCR), K2
(vIL-6) and ORF59 (Chang et al., 2002; Chang et al., 2005; Chen et al.,
2000; Deng et al., 2002; Deng et al., 2000; Haque et al., 2000; Jeong et
al., 2001; Liu et al., 2008; Lukac et al., 2001; Lukac et al., 1999; Song et
al., 2001; Wang and Yuan, 2007; Zhang et al., 1998). In addition to
these delayed-early genes, ORF50 protein also activates the promoter
of a late gene (gB) in transient reporter assays (Damania et al., 2004;
Ziegelbauer et al., 2006).
Fig. 1. Six consensus RBP-Jκ recognition sequences are dispersed in the region encompassing ORFs 45, 46, 47 and 48 of the KSHV genome. Forward or reverse RBP-Jκ recognition
sequences are indicated as GTGGGAA or TTCCCAC. Numbers in the diagram represent nucleotide positions of the KSHV genome (Russo et al., 1996). The black box indicates a
rightward open reading frame, and white boxes indicate leftward open reading frames.
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activates its target genes during the lytic cycle has been extensively
investigated, several details still remain to be addressed (Chang et al.,
2005). The most complicated observation is that many ORF50
response elements (ORF50 REs) identiﬁed in target promoters do
not share conserved DNA sequences (Chang et al., 2005; Lukac et al.,
2001; Song et al., 2003; Ueda et al., 2002). Currently, two subclasses of
the ORF50 REs that contain homologous sequences have been grouped
together and their modes of response to ORF50 protein have been
proposed. Activation of one class of targets, such as the PAN and K12
genes, operates mainly by ORF50 protein directly binding to promoter
DNA (Chang et al., 2002; Song et al., 2002). The related 26-nt response
elements in the PANandK12promoters serve as a direct binding target
for ORF50 protein (Chang et al., 2002; Song et al., 2002). Activation of
the second class of target promoters by ORF50 protein is mediated
through a cellular DNA-binding protein RBP-Jκ (Chang et al., 2005;
Liang et al., 2002). RBP-Jκ, also known as CSL or CBF1, is a sequence-
speciﬁc DNA-binding protein, which is a downstream effector of the
Notch signaling pathway (Lai, 2002). The RBP-Jκ-dependent mecha-
nism has been demonstrated in several ORF50 target promoters, such
as ORF57, ORF6, vMIP-1, K14/ORF74, ORF50, K8 and ORF59 (Chang et
al., 2005; Liang et al., 2002; Liang and Ganem, 2003; Liang and Ganem,
2004; Liu et al., 2008; Wang and Yuan, 2007). All the ORF50 REsFig. 2. The ORF47 gene is expressed in the early stage of viral reactivation. Total RNA w
absence or presence of phosphonoacetic acid (PAA). At different times (12, 24, 36 and 48
examined by northern blot analysis. A 2.7-kb ORF47 mRNA induced by sodium butyrate
loading control.identiﬁed from these promoters contain a conserved or related RBP-Jκ
recognition sequence, GTGGGAA (Tun et al., 1994). In the case of the
ORF57 and vMIP-1 promoters, mutation of the RBP-Jκ-binding site
dramatically abolished the response to ORF50 protein (Chang et al.,
2005). Furthermore, Liang et al. (2002) ﬁrst demonstrated that ORF50
protein failed to activate the ORF57 and ORF6 promoters in RBP-Jκ
deﬁcient cells, while such activation was restored by co-transfection
with an RBP-Jκ expression vector. Since ORF50 protein can directly
interactwith RBP-Jκprotein (Carroll et al., 2006; Papugani et al., 2008),
RBP-Jκ protein may act as a key mediator in cells for recruiting ORF50
protein to the target promoter DNA.
In addition to nucleotide sequence homology and the capacity to
bindORF50 or RBP-Jκ protein in vitro, classiﬁcation of theORF50REs can
be also achieved by measuring their response to DNA-binding deﬁcient
ORF50 mutants (Chang et al., 2005). Previously, we found that several
DNA-binding deﬁcient ORF50mutants retained the capacity to activate
indirect targets, such as the ORF57 and vMIP-1 promoters, but were
markedly defective at activating direct targets, such as the PAN and K12
promoters (Chang et al., 2005). These DNA-binding deﬁcient ORF50
mutants may be useful to classify new cellular or viral targets of ORF50.
In this report, we show that ORF50 can activate the promoter of the
ORF47 gene that encodes glycoprotein L (gL). TheminimalORF50 RE in
ORF47p was mapped to a 25-bp element that contains a consensusas prepared from HH-B2 cells that had been treated with sodium butyrate in the
h) after chemical treatment, expression of ORF50, K8, K8.1 (A) and ORF47 (B) was
was resistant to PAA treatment. Hybridization with H1RNA of RNase P served as a
40 P.-J. Chang et al. / Virology 398 (2010) 38–48RBP-Jκ-binding site. Although there is another consensus RBP-Jκ
recognition sequence nearby in the ORF47 promoter, this element is
bound weakly by RBP-Jκ protein in vitro and confers little ORF50
responsiveness. Thus a conserved RBP-Jκ sequence itself is not
sufﬁcient to confer an ORF50 response. By study of mutant ORF50
response elements from the ORF 47p and four homologous RBP-Jκ-
binding elements from the human genome, we demonstrate that not
all elements bound by RBP-Jκ protein mediate ORF50 responsiveness.
Results
ORF47 behaves with early gene kinetics during lytic replication
RBP-Jκ elements have been implicated to play a critical role in
regulating ORF50 promoter activity (Chang et al., 2005; Liang andFig. 3.Deﬁning the ORF50 response element (ORF50 RE) of the ORF47 promoter. (A) Transcri
of deletions of the ORF47 promoter in pCAT-Basic are indicated. The numbers in the diagra
transcriptional start site (+1). Two RBP-Jκ-binding elements in the ORF47 promoter are de
with pCMV or pCMV-ORF50 were measured in BJAB cells. (B) Sequence alignment of the RBP
vMIP-1 promoters. (C) Response to ORF50 protein of the A-RBP-Jκ and B-RBP-Jκ elements an
and B-RBP-Jκ. Both forward and reverse (rev) orientations of the A-RBP-Jκ and B-RBP-Jκ elGanem, 2003). Analysis of sequences upstream of the ORF50 gene
revealed six consensus RBP-Jκ recognition sequences, GTGGGAA (Tun
et al., 1994), which were dispersed in the region between the ORF45
and the ORF48 genes (Fig. 1). Two of these RBP-Jκ elements, located at
nucleotides (nt) 70,082 to 70,088 and 70,130 to 70,136, were found in
the promoter region of the ORF47 gene (Fig. 1). The ORF47 gene
encodes a homolog of herpesvirus glycoprotein L (gL) (Russo et al.,
1996), which was thought to be a late gene during lytic replication.
Since several viral promoters containing the RBP-Jκ recognition
sequence belong to the class of delayed-early genes that are regulated
by ORF50 protein, we speculated that the ORF47 gene could be a
target of ORF50 protein and behave as a delayed-early gene.
To analyze the expression kinetics of the ORF47 gene during the lytic
cycle, northern analysis was carried out using RNA samples of HH-B2
cells treated with n-butyrate. In one set of cultured cells,ptional activation of deletion mutants of the ORF47 promoter by ORF50 protein. A series
m represent nucleotide positions of the KSHV genome and the positions relative to the
signated A-RBP-Jκ and B-RBP-Jκ, respectively. CAT activities of reporters co-transfected
-Jκ-containing elements in the ORF47 promoter and in the ORF50 REs of the ORF57 and
d ﬂanking sequence in pE4CAT. The region from−190 to−84 contains both A-RBP-Jκ
ements in pE4CAT were examined for their response to ORF50 protein.
Fig. 4. RBP-Jκ protein speciﬁcally binds to the ORF50 RE of the ORF47 promoter. (A) EMSAs of A-RBP-Jκ (−139 to −100) and B-RBP-Jκ (−188 to −149). The radioactive probes
(A-RBP-Jκ or B-RBP-Jκ) were incubated with cell extracts of HKB5/B5 transfected with pCMV, pCMV-ORF50, or pCMV-ORF50(KK/EE) and analyzed by EMSA. The different protein/
DNA complexes are indicated. (B) Cross-competition with various ORF50 REs from viral promoters (ORF57p and PANp) in EMSA. The indicated cold competitors used in EMSA were
in 50- and 100-fold molar excesses over hot probe DNA. (C) Binding of the A-RBP-Jκ element by ectopically expressed RBP-Jκ protein. Extract of HH-B2 cells transfected with pCMV-
FLAG-RBP-Jκ was used in EMSA; a cross-competition assay was performed to determine the binding speciﬁcity of RBP-Jκ protein to the probe.
41P.-J. Chang et al. / Virology 398 (2010) 38–48phosphonoacetic acid (PAA), an inhibitor of KSHV lytic DNA synthesis,
was added to block viral DNA synthesis and late gene expression (Sun et
al., 1999). After treatment with n-butyrate, a 2.7-kb mRNA containing
ORF47 was markedly induced (Fig. 2B). The 2.7-kb transcript was a
polycistronicmRNA containing open reading frames 47, 46 and 45 (data
not shown). PAA treatment only slightly affected ORF47 mRNA
expression, indicating that the ORF47 gene was not a late gene. The
same RNA samples were also used for detecting expression of ORF50
(immediate-early gene), K8 (delayed-early gene) and K8.1 (late gene),
which are also part of a polycistronic transcript. Like the ORF47 mRNA,
expression of the ORF50 and K8mRNAs was resistant to PAA treatment
(Fig. 2A). By contrast, treatment with PAA completely abolished
expression of the K8.1 gene (Fig. 2A). These results indicated that the
ORF47 gene belongs to the early gene family.
The ORF50 response element within the ORF47 promoter contains an
RBP-Jκ-binding site
Using total RNAs of HH-B2 cells treated with n-butyrate, the
transcriptional start site of the ORF47 promoter was mapped to nt
69,965 of the KSHV genome by RACE (rapid ampliﬁcation of cDNA
ends). A consensus TATA box, TATAAAA, was present between −30Fig. 5. Transcriptional activation of the PANp, K12p and ORF47p elements by ORF50 protein a
capacities of wild-type ORF50 and ORF50(R161A) on the identiﬁed ORF50 REs from the PAand−24 relative to the transcription start site (Fig. 3A). To determine
whether the ORF47 promoter was a target of ORF50 protein, a 1008-
bp DNA fragment corresponding to the promoter region from −963
to+46 was fused 5′ to a CAT reporter. Co-transfection of the ORF47p/
CAT reporter plasmid with an ORF50 expression plasmid led to a 29-
fold enhancement of CAT activity in BJAB cells (Fig. 3A). This result
demonstrated that the ORF47 promoter was a target of ORF50 protein.
To deﬁne the location of the ORF50 response element (ORF50 RE)
in the ORF47 promoter, a series of deletion mutants were constructed
and reporter assays were performed. As shown in Fig. 3A, 5′ deletion
to -190 relative to the ORF47 transcriptional start site still retained
nearly maximal response to ORF50 protein. However, further deletion
to −84, which removed the two putative RBP-Jκ-binding elements,
completely abolished the response of pORF47p/CAT to ORF50 protein
(Fig. 3A, ORF47p-D5). These results indicated that the 107-bp region
between−190 and−84 in the ORF47 promoter contained elements
required for ORF50 responsiveness. Two consensus RBP-Jκ recogni-
tion sequences were present in this region; these were designated A-
RBP-Jκ (−139 to−100) and B-RBP-Jκ (−188 to−149) (Fig. 3A and
B). Both elements in the ORF47 promoter shared sequence homology
with the ORF50 REs of the ORF57 and vMIP1 promoters (Fig. 3B). To
verify the importance of the region between −190 and −84 in thend ORF50(R161A), a DNA-binding deﬁcient point mutant of ORF50. The transcriptional
N, K12 and ORF47 promoters were determined by CAT assay in BJAB cells.
Fig. 6. RBP-Jκ contributes to activation of the ORF47 promoter by ORF50. (A) A luciferase
reporter construct containing theORF47 promoter. The region from−958 to+34 of the
ORF47 promoter was cloned 5′ to the luciferase gene of pGL3-Basic (Promega). The
resulting plasmid pORF47p/luc and the control vector (pGL3-Basic) were assessed for
ORF50-responsiveness in BJAB (B), 293T (C), OT13 (D) and OT11 cells (E). OT11 is an
RBP-Jκ knockoutmouseﬁbroblast cell line. A rescue experimentwas carried outwith the
RBP-Jκ expression vector introduced into OT11. All cells were harvested 48 h post-
transfection. Fold-activation was calculated by comparing luciferase activity stimulated
by effectors to that stimulated by the control vector. The values of fold-activation
represent at least three independent transfections with duplicate samples in each
transfection.
42 P.-J. Chang et al. / Virology 398 (2010) 38–48ORF47 promoter, this region was fused to the heterologous
adenovirus E4 promoter and its response to ORF50 protein was
examined (Fig. 3C). When the reporter containing the entire −190/
−84 region was co-transfected with an ORF50-expressing plasmid in
cells, CAT activity was activated over 200-fold [Fig. 3C, A+B(−190/
−84)−E4]. When either the A-RBP-Jκ(−139/−100) or B-RBP-
Jκ(−188/−149) element in pE4CAT was co-transfected with the
ORF50-expressing plasmid, only the reporter plasmid containing the
A-RBP-Jκ(−139/−100) element conferred robust activation by
ORF50 protein. Forward or reverse orientations of the A-RBP-Jκ or
B-RBP-Jκ in pE4CAT did not signiﬁcantly change their response to
ORF50 protein (Fig. 3B and C). This experiment showed that not all
elements that ﬁt a consensus RBP-Jκ recognition sequence confer
ORF50 responsiveness.
RBP-Jκ protein binds strongly to the A-RBP-Jκ element, but weakly to the
B-RBP-Jκ element
To understand the mechanism underlying the differential re-
sponse of the A-and B-RBP-Jκ elements to ORF50 protein, binding of
ORF50 and cellular proteins to the A-RBP-Jκ and B-RBP-Jκ elements
was examined (Fig. 4). Total cell lysates of HKB5/B5 cells transfected
with empty vector, pCMV-ORF50 or pCMV-ORF50(KK/EE) were used
in electrophoretic mobility shift assays (EMSAs). The ORF50(KK/EE)
protein contains two amino acid substitutions at positions K527 and
K528 which markedly enhance DNA-binding capacity (Chang and
Miller, 2004; Chang et al., 2008). As shown in Fig. 4A, neither wild-
type ORF50 nor the KK/EE mutant bound the ORF47 promoter
elements in vitro. However, several cellular proteins bound to the A-
RBP-Jκ and B-RBP-Jκ elements in EMSA experiments and the pattern
of binding of cellular proteins to the two elements was different
(Fig. 4A). The variation in cellular proteins binding to A-RBP-Jκ and B-
RBP-Jκ was conﬁrmed by cross-competition with cold oligonucleo-
tides (Fig. 4B). Cold A-RBP-Jκ competitor, but not B-RBP-Jκ cold
competitor, signiﬁcantly reduced binding of cellular proteins to the A-
RBP-Jκ element (Fig. 4B). This result suggested that speciﬁc cellular
proteins bound to the A-RBP-Jκ element may be critical for mediating
the ORF50 transactivation.
Two distinct ORF50 REs from the ORF57p, an indirect target, and
PANp, a direct target promoter, were also used as cold competitors in
EMSA. The ORF57p element, but not the PANp element, completely
disrupted the formation of all complexes in EMSA (Fig. 4B). These data
suggest that the A-RBP-Jκ and ORF57 elements may possess binding
sites for related cellular proteins, especially for the protein component
in abundant complex “A4”. RBP-Jκ was a likely candidate protein
component in complex A4.
To determine whether RBP-Jκ protein bound to the A-RBP-Jκ
element, protein extracts of HKB5/B5 cells transfected with a plasmid
expressing RBP-Jκ protein were used in EMSA. An abundant DNA/
RBP-Jκ complex could be detected, which co-migrated with complex
A4 (Fig. 4C). In cross-competition analysis, a mutant competitor with
point mutations in the RBP-Jκ site (Fig. 7A) lost its competitive ability
in EMSA [Fig. 4C, A-RBP-Jκ(m)]. The B-RBP-Jκ cold competitor
behaved more like A-RBP-Jκ(m) than the A-RBP-Jκ element. It did
not signiﬁcantly affect formation of the DNA/RBP-Jκ complex. These
results indicated that RBP-Jκ protein was the major component of the
complex A4. Although the B-RBP-Jκ element contains a consensus
RBP-Jκ-binding site, it did not efﬁciently bind RBP-Jκ protein.
The A-RBP-Jκ element is responsive to a DNA-binding deﬁcient ORF50
mutant
Previously, we showed that several DNA-binding deﬁcient ORF50
mutants were capable of activating the indirect targets of ORF50 such
as ORF57p and vMIP1p (Chang et al., 2005). Here, we determined
whether ORF50(R161A), a DNA-binding-deﬁcient ORF50 mutant,could activate the ORF47 promoter. As shown in Fig. 5, ORF50
(R161A) failed to activate the PAN and K12 promoters, two direct
targets of ORF50, in a CAT reporter assay. By contrast, ORF50(R161A)
retained the capacity to strongly activate the ORF47 promoter (70-
fold), although the transactivation function of the R161A mutant was
lower than that of wild-type ORF50 (Fig. 5). These results conﬁrmed
the experiment illustrated in Fig. 4, showing that ORF50 protein did
not bind directly to the ORF47p. Activation of ORF47p by ORF50
protein is mediated, at least in part, through an indirect interaction
with DNA (see Discussion, Fig. 10).
Activation of the ORF47 promoter by ORF50 protein is dependent on the
expression of RBP-Jκ
The experiment illustrated in Fig. 4 demonstrated that RBP-Jκ
protein bound to the ORF50 RE of the ORF47 promoter, but did not
address the critical functional role of RBP-Jκ protein in activation of the
ORF47 promoter by ORF50. A reporter was constructed in which
ORF47p was fused to luciferase (Fig. 6A). A reporter assay was
conducted in 4 different cell backgrounds, including BJAB, 293T, OT11
(anRBP-Jκ-null cell line) andOT13 (awild-type counterpart cell line of
OT11). Co-transfection of the ORF47p/luciferase reporter with an
expression vector for ORF50 revealed a 17-, 22- and 52-fold
enhancement of luciferase expression in BJAB, 293T and OT13 cells.
ORF50 protein activated ORF47p/luc at background levels in OT11
cells (Fig. 6). Transactivation of the ORF47p/Luc reporter by ORF50 in
OT11 cells could be rescued by ectopic expression of RBP-Jκ (Fig. 6E).
Fig. 7. Optimal ORF50 responsiveness of the A-RBP-Jκ element requires both a consensus RBP-Jκ site and ﬂanking sequences. (A) Effect of deletions or mutations in the A-RBP-Jκ
element on capacity to bindRBP-Jκprotein and to respond to theORF50 protein. The relative binding capacity of themutant elements to RBP-Jκ (a component of complexA4) and toA1
protein (a component of complex A1) was measured by competition experiments in EMSA. ORF50 responsiveness was determined by CAT assays in BJAB cells as described in Fig. 3.
(B) Cross-competition analysis by the A-RBP-Jκmutant elements in EMSA. The radioactive probe and an extract of HKB5/B5 cells transfected with ORF50 protein were used in EMSA.
The cold competitors Pt-1, Pt-2 and Pt-3 as described in (A) were used for competition analysis. They were added in 50 and 100-fold molar excesses over the hot probe.
43P.-J. Chang et al. / Virology 398 (2010) 38–48This result indicated that RBP-Jκ plays an essential role in the
activation of the ORF47 promoter by ORF50.
The consensus RBP-Jκ recognition site and 5′ ﬂanking sequence in the
A-RBP-Jκ element are required for an optimal ORF50 response
To determine the minimal nucleotide requirement of the A-RBP-Jκ
element for ORF50 responsiveness, deletions or pointmutations in the
A-RBP-Jκ element were created in the reporter plasmid (Fig. 7A).
Mutation of the RBP-Jκ site in the A-RBP-Jκ element resulted in
complete loss of ORF50 activation [Fig. 7A, A-RBP-Jκ(m)]. Point
mutation in the RBP-Jκ recognition site also eliminated speciﬁc
binding by RBP-Jκ protein (Figs. 4C and 7B). These results conﬁrmed
that binding of RBP-Jκ protein to the response element correlatedwith
transactivation by ORF50. Deletions 5′ and 3′ to the consensus RBP-Jκ
site in the A-RBP-Jκ element in pE4CAT were also examined for their
responses to ORF50 protein. Deletions of all but one nucleotide of 3′
ﬂanking sequences did not appreciably alter the response to ORF50;
however, 5′ deletions reduced the response to ORF50 by 72% (Fig. 7A,
5′-D17). Thus, optimal ORF50 transactivation required both the RBP-
Jκ-binding site and 5′ ﬂanking sequences in ORF47p. In EMSA
experiments with constructs containing 5′deletions in ORF47p theformationof RBP-Jκ/DNAcomplexA4 and complexA1was diminished
(Fig. 7A; data not shown).
Point mutations in the 5′ ﬂanking sequences were characterized
for ORF50 responsiveness and for binding of cellular proteins. In CAT
reporter assays, adjacent two nucleotide point mutations in the 5′
ﬂanking region decreased ORF50 transactivation by 47%, 60% and 87%
inmutants Pt-1, Pt-2 and Pt-3, respectively (Fig. 7B). ORF50-mediated
transactivation was dramatically reduced in the Pt-3 mutant
promoter; yet this mutant retained strong DNA-binding afﬁnity for
RBP-Jκ protein (Figs. 7A and B). To conﬁrm these results, the luciferase
reporter system was used for further examining the importance of
these mutations in ORF50-mediated transactivation (Fig. 8A). As
shown in Fig. 8A, the luciferase assay also showed that mutations Pt-3,
directly ﬂanking the RBP-Jκ recognition site of the A-RBP-Jκ element,
reduced ORF50 responsiveness by 80%. The DNA-binding assay with a
radio-labeled probe was repeated in an EMSA experiment using a
biotin-labeled probe (Fig. 8B). Identical results were obtained when
compared to that using a radioactive probe (Fig. 7B). Mutants in A-
RBP-Jκ, such as Pt-3, which were markedly reduced in transcriptional
response to ORF50 still bound strongly to RBP-Jκ protein in EMSA.
These results indicate that binding of RBP-Jκ protein to the target DNA
is separable from transactivation by ORF50.
Fig. 8. Functional characterization of the 5′ ﬂanking sequences in the A-RBP-Jκ (−139
to−100) element by luciferase assay and by non-isotopic EMSA. (A)Wild-type A-RBP-
Jκ (−139 to−100) element and the mutant elements (Pt-1, Pt-2 and Pt-3 as shown in
Fig. 7A) were inserted in pE4-Luc, a plasmid containing the luciferase reporter gene. A
luciferase assay was carried out in HKB5/B5 cells 48 h post-transfection. Relative
luciferase activities were measured as fold-activation by ORF50 from at least three
independent transfections. (B) EMSA using a biotin-labeled probe. The annealed
double-stranded oligonucleotide was labeled with biotin-11-UTP using terminal
deoxynucleotidyl transferase. Extracts of HKB5/B5 cells transfected with pCMV or
pCMV-ORF50 were prepared for EMSA. Cold competitors used in EMSA were in 50- and
100-fold molar excess over the hot probe. NS: nonspeciﬁc complex.
44 P.-J. Chang et al. / Virology 398 (2010) 38–48RBP-Jκ-binding elements from human DNA, homologous to those in
ORF47p, confer ORF50 responsiveness
The results from Figs. 7 and 8 show that not all RBP-Jκ-binding
elements conferred equivalent responsiveness to ORF50. This phe-
nomenon was validated with four DNA sequences resembling the
A-RBP-Jκ element of ORF47p that were identiﬁed in the human
genome (Fig. 9). Each homologous element contained a consensus
RBP-Jκ recognition site and shared at least 16 consecutive identical
nucleotides with the A-RBP-Jκ element of ORF47p (Fig. 9A). The
sequences from cellular DNA shared from 3 to 5 nucleotides in the 5′
ﬂanking region and from 4 to 6 nucleotides in the 3′ ﬂanking region
with the A-RBP-Jκ element. In luciferase reporter assays, these cellular
RBP-Jκ elements displayedheterogeneous responses toORF50protein.
The elements from chromosome 2 and 18 exhibited little response toORF50, while the element from chromosome 5 was strongly
responsive to ORF50 protein (Fig. 9B). When these homologous
elements were used as cold competitors in EMSA, all human DNA
elements blocked formation of complex A4 as efﬁciently as did the A-
RBP-Jκ element from ORF47p (Fig. 9C). Direct binding of RBP-Jκ
protein to these elements was further demonstrated using ectopically
expressed RBP-Jκ protein (Fig. 9D). Taken together, these results
conﬁrmed that not all DNA sequences that efﬁciently bind RBP-Jκ
protein confer a transcriptional response to ORF50 protein.
Discussion
This report provides new information about regulation of
expression of the ORF47 gene of KSHV and describes novel ﬁndings
about the mechanisms of activation of the ORF47 promoter (ORF47p)
through interactions of ORF50 protein and RBP-Jκ. Three novel
ﬁndings about the role of RBP-Jκ in activation of ORF47p by ORF50
include the following: i) While RBP-Jκ is essential for activation of
ORF47p by ORF50 protein, neither the presence of RBP-Jκ consensus
sequences in the promoter nor binding of RBP-Jκ to a DNA sequence
ensures a robust transcriptional response to ORF50 protein. ii)
Sequences ﬂanking the RBP-Jκ consensus site contribute to activation
by ORF50 protein. iii) Cellular DNA contains RBP-Jκ consensus
sequences, ﬂanked by sequences that are homologous to those
present in the ORF47 promoter. All of these cellular sequences bind
RBP-Jκ, but only some of them respond strongly to ORF50 protein.
Regulation of expression of ORF47
ORF47, which encodes a homologue of herpesvirus glycoprotein L,
behaves with early gene kinetics (Fig. 2). In Herpes simplex virus and
Pseudorabies virus, the equivalent gene UL1 is classiﬁed as a member
of the βγ or early-late gene family (Dean and Cheung, 1993; Rajcani et
al., 2004; Singh and Wagner, 1993), but little information is available
about the kinetic class of gL in the gamma herpesviruses of which
KSHV is a member. Although the mRNA that encodes ORF47 (gL) is
expressed at an early kinetic stage, the pattern and kinetics of gL
protein expression remains to be determined. Further experiments
aimed at understanding the correlation between the kinetics of
expression of gL mRNA and protein will be needed to elucidate
whether gL is subject to post-transcriptional regulation.
The lytic 2.7-kb ORF47 transcript is a component of a polycistronic
early leftward mRNA encompassing ORFs 47, 46, and 45 (Fig. 1).
(More details about the structure of this transcript will be provided
separately.) In simian varicella virus ORF47 and ORF46 (uracil DNA
glycosylase) share a common 5′RNA start site (Ashburn and Gray,
2002). We map the start site of ORF47 transcription and we identify a
sequence, located in the promoter of the ORF 47 gene,−139 to−100
relative to the start of transcription, that confers activation by ORF50
protein (Fig. 3). Neither wild-type ORF50 protein, nor a mutant of
ORF50 protein (K527E/K528E) that is enhanced in binding to DNA
(Chang andMiller, 2004; Chang et al., 2008) detectably binds in EMSA
to the ORF50 response element in the ORF47 promoter (Fig. 4).
Moreover, we ﬁnd that the ORF50 response element in ORF47p can be
activated by a mutant of ORF50 protein (R161A) that does not bind to
DNA (Fig. 5). Therefore, we conclude that ORF47p is activated by an
indirect mechanism, rather than by ORF50 binding directly to DNA.
RBP-Jκ plays an essential role in activation of ORF47p by ORF50 protein
The ORF50 response element from −139 to −100 in ORF47p
contains an RBP-Jκ consensus sequence that is homologous to RBP-Jκ
sites in the promoters of two other KSHV genes, ORF57 and vMIP-1,
that are activated by ORF50 through an indirect mechanism (Fig. 3B).
Therefore we designate the ORF50 response element, A-RBP-Jκ.
Another RBP-Jκ consensus sequence, GTGGGAAwas located upstream
Fig. 9. ORF47p-related elements from human DNA confer ORF50-responsiveness. (A) Alignment of DNA sequences of the ORF47p-related elements. Four elements encompassing
sequences homologous to the A-RBP-Jκ (-139 to-100) element were identiﬁed from human chromosome 2, 5, 7 and 18 by nucleotide-nucleotide BLAST (NCBI). Numbers indicate the
nucleotide positions of the individual sequences in databank. Accession no: AC082651.6 (Ch 2); AC091907.4 (Ch5); AC002454.1 (Ch 7); AC091691.7 (Ch 18). (B) Response of the
ORF47p-related elements in pE4-Luc to ORF50 protein. The luciferase assays were performed in HKB5/B5 cells. (C) Cross-competition analysis in EMSA. A biotin-labeled A-RBP-Jκ
probe was used in EMSA. The indicated cold competitors used in EMSA were in 25- and 50-fold molar excess over probe DNA. (D) Binding of RBP-Jκ protein to the ORF47p-related
human DNA elements. All probes were labeled with biotin. Cell extracts of HKB5/B5 transfected with pCMV or pCMV-FLAG-RBP-Jκwere used in EMSA. Antibody to FLAGwas used to
supershift the protein/DNA complex. SS: supershifted complex
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conferred only a minimal 5-fold response to ORF50 protein that was
4% of the response of A-RBP-Jκ (Fig. 3C). The B-RBP-Jκ element also
bound RBP-Jκ protein with considerably weaker afﬁnity than did A-
RBP-Jκ (Fig. 4). The A- and B-RBP-Jκ elements also bound different
cellular proteins. Therefore not all DNA elements that contain a
consensus RBP-Jκ sequence confer an equivalent response to ORF50
protein and not all RBP-Jκ sequences are equally capable of binding
RBP-Jκ protein. Binding of other cellular proteins may affect the
binding of RBP-Jκ, ORF50 protein and the activation response.
Nonetheless, the capacity to bind RBP-Jκ is an important compo-
nent of an indirect ORF50 response element. A mutant A-RBP-Jκ DNA
element, with 3 nucleotide changes in the RBP-Jκ consensus, that has
little or no capacity to bind RBP-Jκ, does not confer a transcriptional
response to ORF50 protein (Figs. 7 and 8). ORF50 protein does not
activate ORF47p inmouse cells with a knockout of RBP-Jκ (Fig. 6). This
deﬁciency can be rectiﬁed by providing RBP-Jκ in trans.
Neither an RBP-Jκ consensus site nor RBP-Jκ binding is sufﬁcient to
provide a robust response to ORF50 protein
The ﬁnding (Fig. 3) that the B-RBP-Jκ element in ORF47p was very
weakly activated by ORF50 protein prompted us to search for adjacentelements thatmight inﬂuence the response. In preliminary experiments
conducted by one of us (Joseph Boonsiri) we found, using chimeric
reporter constructswithportions of A-RBP-Jκ fused to B-RBP-Jκ, that the
5′ﬂanking sequences of A-RBP-Jκwere essential to confer a full response
toORF50(datanot shown). The resulting chimeric constructwas similar
tomutants3′-D15or 3′-D7(Fig. 7A) inwhich sequencedeleted fromthe
promoter was replaced with sequence provided by vector DNA. These
mutants also conferred a wild-type response to ORF50 protein. In
further work (Fig. 7 and data not shown)we found that deletions of the
ﬂanking sequences 5′ to theA-RBP-Jκ site had a greater effect than those
3′ to the site in reducing activation by ORF50 protein. Moreover, point
mutations in the 5′ ﬂanking sequence of A-RBP-Jκ reduced the response
(Figs. 7 and 8). However, a surprising ﬁnding was that these 5′ point
mutations, even those such as Pt-3 that reduced the response to ORF50
bymore than 85%, did not signiﬁcantly affect binding of RBP-Jκ to the A-
RBP-Jκ element (Figs. 7 and 8).
The two nucleotide substitutions in mutant Pt-3 were more
deleterious to a response to ORF50 protein than was the entire 5′
deletion in mutant 5′-D15 (Fig. 7A). This paradoxical result can be
explained by vector DNA sequences present in the 5′ deletion
construct 5′-D15. In this mutant vector DNA has provided 4
nucleotides that are identical to those present in the ORF47 promoter.
The sequence of the 5 nucleotides 5′ to the RBP-Jκ site was TCTAT
Fig. 10.Models depicting possible mechanisms of ORF50-mediated transactivation through RBP-Jκ protein. In addition to the RBP-Jκ-binding site, an auxiliary ﬂanking DNA element
is partly required for optimal ORF50-mediated transactivation. The speciﬁc cis-acting region may provide a platform for binding of other cellular protein(s) (designated×in model I)
or for trapping the ORF50 protein (model II). This event may enhance the formation and stability of the active ORF50/RBP-Jκ/DNA ternary complex. The recognition sequence of RBP-
Jκ protein in target DNAmay be changed upon the recruitment of ORF50 protein (model III). During the period of the ORF50-mediated transcriptional activation, the speciﬁc ﬂanking
sequence may provide a new binding sequence for RBP-Jκ.
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comparable ﬂanking sequence of the two-residue substitutionmutant
Pt-3 was TCTTC. It is likely that the replaced vector sequence has
corrected the 5′ deletion.
Since RBP-Jκ-binding sites are not restricted to the viral genome,
we extended the scope of our study by examining the relationship
among ORF50, RBP-Jκ and cellular DNA. The correlation between
binding of RBP-Jκ and response to activation by ORF50 protein was
examined in studies of cellular DNA sequences that contained
consensus RBP-Jκ sites ﬂanked by short stretches of sequences
identical to those in A-RBP-Jκ. All four cellular DNA sequences
efﬁciently bound RBP-Jκ protein in EMSA, whether assessed as cold
competitors of A-RBP-Jκ binding or directly as probes for binding RBP-
Jκ protein (Fig. 9). However, it is not yet known whether the
interactions of ORF50 protein with these cellular RBP-Jκ sites control
cellular gene expression or affect viral replication.
These experiments conﬁrmed the conclusion that binding of RBP-
Jκ to DNA is not the sole determinant of transactivation by ORF50
protein. Two previous studies support this conclusion. In studies of
the ORF57 promoter Lukac et al. (2001) and Carroll et al. (2006)
described mutations ﬂanking the consensus RBP-Jκ site that resulted
in reduction of response to ORF50 protein. However, these studies
provided limited information about the effect of these mutations on
binding of RBP-Jκ protein. Papugani et al. (2008) showed that a DNA-
binding-defective mutant of ORF50 (K152E) was capable of forming a
DNA/RBP-Jκ/ORF50 ternary complex, but was not sufﬁcient to
mediate ORF50 responsiveness. Thus, after full assembly of the
ternary complex recruitment of additional co-factors may be essential
to promote activation.
Models for the role of sequences ﬂanking the core RBP-Jκ element
We propose three models to explain the importance of sequences
ﬂanking the RBP-Jκ core element in mediating activation by ORF50
protein (Fig. 10). In the ﬁrst model, one or more auxiliary proteins
bind the ﬂanking sequence and are required for enhancing the
formation of the ORF50/RBP-Jκ/DNA ternary complex and for
subsequent ORF50 activity. Since elimination of the core RBP-Jκ
sequence destroys the response to ORF50, binding of the auxiliary
factor(s) alone to target DNA is not sufﬁcient to confer a response to
ORF50. The only possible clue to the identity of such an auxiliary
protein, in the data presented here, is that two of the three point
mutants in ﬂanking DNA sequence that reduce ORF50 activity also are
deﬁcient in binding to protein in complex A1 (Fig. 7). However, Pt-3,
which is most deﬁcient in activation by ORF50, appears to bind
protein A1 at levels comparable to wild-type A-RBP-Jκ. There may be
more than one auxiliary protein.In the second model, the ﬂanking sequence may provide a
transient docking site for ORF50 protein. Such an interaction may
favor and enhance the association between ORF50 and RBP-Jκ. Such a
model would predict a direct interaction between ORF50 and cognate
DNA. We could not detect any direct interaction between ORF50
protein and target DNA in our experiments using EMSA (Fig. 4A).
However, we cannot rule out a weak association between ORF50
protein and DNA that cannot be detected using EMSA with cell
extracts. Previously Liao et al. showed that partially puriﬁed ORF50
protein could bind to tandem arrays of A/T rich trinucleotidemotifs in
vitro (Liao et al., 2003). One such A/T trinucleotide motif is present
immediately 5′ of the RBP-Jκ core element in the ORF47p (Fig. 3B). Pt-
3 destroys this motif.
In the third model, recruitment of ORF50 protein to the target
promoter by RBP-Jκ protein may induce a conformational change of
RBP-Jκ. The new conﬁguration of RBP-Jκ may be competent to
interact with an expanded region of DNA. In effect, recruitment of
ORF50 protein may create a new upstream binding site for RBP-Jκ.
None of these models is mutually exclusive. To better distinguish
among these models in future studies, DNase footprinting with
puriﬁed proteins may elucidate the detailed interaction between
RBP-Jκ protein and target DNA in the presence or absence of ORF50
protein.
In summary, our study shows that binding of RBP-Jκ to the
ORF47p, while a critical component of activation by ORF50, by itself
is not sufﬁcient to confer a transcriptional response. Sequences
ﬂanking the RBP-Jκ core element are essential for regulating the
magnitude of the response and presumably for selecting those viral
and cellular gene targets whose expression is modulated by ORF50
protein.
Materials and methods
Cell cultures and transfections
BJAB cells are derived from a B-cell lymphoma and grown in RPMI
1640 medium with 8% fetal bovine serum (FBS). 293T is human
embryonic kidney cell line transformed with the E1 region of
adenovirus and the simian virus 40 T antigen. The 293T cells were
grown in high-glucose DMEM supplemented with 10% FBS. HKB5/B5
is an EBV-negative cell line formed by fusion of HH514-16 cells with
293T cells (Chang et al., 2002). HH-B2 cells are derived from a primary
effusion lymphoma infected with KSHV (Gradoville et al., 2000).
HKB5/B5 and HH-B2 cells were cultured in RPMI 1640 medium
supplemented with 8% and 15% FBS, respectively. Mouse RBP-Jκ−/−
(OT11) and wild-type (OT13) embryonic ﬁbroblast cell lines (Kato et
al., 1997) were kindly provided by T. Honjo (Kyoto University, Kyoto,
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10% FBS and 100 U/ml of mouse interferon gamma. Transfection
assays were performed in BJAB and HH-B2 cells using electroporation,
in HKB5/B5 using DMRIE-C reagent (Invitrogen), and in 293T, OT11
and OT13 using Lipofectamine 2000.
Plasmid construction
For construction of CAT reporter plasmids, DNA fragments of the
KSHV ORF47 promoter were ampliﬁed by PCR from pORF50p
(−3870/+20)/CAT (Chang et al., 2005) and cloned into pCAT-
Basic (Promega) digested with HindIII and PstI. The plasmids
including pE4CAT, pPAN(−91/−58)/E4CAT, pK12(−105/−72)/
E4CAT, pCMV-ORF50, pCMV-ORF50(KK/EE), pCMV-ORF50(R161A)
and pCMV-FLAG-RBP-Jκ were described previously (Chang and
Miller, 2004; Chang et al., 2002). The PCR-ampliﬁed DNA fragments
or double-stranded oligonucleotides encompassing the RBP-Jκ
recognition site of the ORF47 promoter were cloned into pE4CAT
digested with HindIII and XbaI. For constructing the luciferase
reporter plasmid, the promoter region from −958 to +34 of the
ORF47 gene was cloned into pGL3-Basic (Promega). The reporter
plasmid pE4-Luc was constructed by inserting a minimal E4
promoter of adenovirus into the pGL3-Basic. Various double-
stranded oligonucleotides with a consensus RBP-Jκ site were cloned
into pE4-Luc digested with NheI and XhoI.
CAT and luciferase assays
In CAT assays, BJAB cells (1.0×107) were transfected with 5 μg of
pCMV-ORF50 or pCMV vector and 5 μg of reporter DNA. CAT activity
was determined as described elsewhere (Serio et al., 1997). Activation
was calculated as percent acetylation of chloramphenicol in the
presence of activator divided by percent acetylation in the presence of
control vector. In luciferase assays, 293T, HKB5/B5, OT11 and OT13
cells (7×105) were transfected with a ﬁxed amount (1 μg) plasmid
DNA, including effector plasmids and the reporter. The reporter assays
were carried out according to manufacturer's protocol for the
luciferase reporter assay system (Promega).
Rapid ampliﬁcation of 5′ cDNA ends
To map the transcriptional initiation site of the ORF47 gene, the
GeneRacer kit (Invitrogen) was used. Brieﬂy, HH-B2 cells were treated
with 3mM sodium butyrate for 40 h and total RNAwas prepared from
the treated cells. Two micrograms of total RNA was treated with calf
intestinal phosphatase to remove the 5′ phosphates of truncated
mRNA and non-mRNA. After decapping of full-length mRNA by
tobacco acid pyrophophatase, an RNA oligonucleotide was ligated to
the mRNA by T4 RNA ligase. Reverse transcription was performed to
obtain the ﬁrst-strand cDNA by random primers. Subsequent PCR (or
nested PCR) ampliﬁcation was carried out using an ORF47 speciﬁc
primer 5′CTTTTGACCTGCGTGCGC (or nested ORF47 speciﬁc primer 5′
CTGCTTTTAGCCCGAGTCTGACTT) and the primers provided by kit. The
ampliﬁed DNA fragments were cloned and sequenced. Nine out of the
10 clones contained the same initiation site at nucleotide 69,965 of
KSHV genome (Russo et al., 1996).
Electrophoretic mobility shift assays (EMSAs)
Cell extracts prepared from transfected HKB5/B5 cells were used
for EMSAs. HKB5/B5 cells were suspended in a lysis buffer (0.42 M
NaCl, 20 mM HEPES [pH 7.5], 25% glycerol, 1.5 mM MgCl2, 0.2 mM
EDTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl ﬂuoride, 2 μg
aprotinin per milliliter). Lysates were centrifuged at 90,000 rpm at
4 °C for 15 min in a benchtop ultracentrifuge and supernatants were
harvested and stored at −80 °C. Annealed double-stranded oligonu-cleotides were end-labeled with 32P using T4 polynucleotide kinase or
labeled with biotin-11-UTP using terminal deoxynucleotidyl trans-
ferase (PIERCE). Binding reactions contained 10 to 15 μg of protein
extract in a solution containing 10 mM HEPES (pH 7.5), 50 mM NaCl,
2 mM MgCl2, 2.5 μM ZnSO4, 0.5 mM EDTA, 1 mM dithiothreitol, 15%
glycerol and 0.5 μg poly(dIdC) in a total volume of 20 μl. For
competition assays, unlabeled competitor DNA was added to the
initial reaction mix. Anti-FLAG antibody to the FLAG-RBP-Jκ protein
was used for supershift analysis.
Northern blot analysis
HH-B2 cells were treated with 3 mM sodium butyrate in the
presence or absence of 200 μg phosphonoacetic acid (PAA) per
milliliter for 12, 24, 36 and 48 h. Total cellular RNAs from the treated
HH-B2 cells (1.2×107) were prepared with an RNeasy kit (QIAGEN),
fractionated on 1% formaldehyde-agarose gels, and transferred to
nylon membranes (Hybond-N; Amershann Pharmacia Biotec). All
probes were labeled by the random-primed method. Detection of the
ORF50, K8 and K8.1 RNAs has been described previously (Chang et al.,
2005). For detection of ORF47 RNA, DNA fragments corresponding to
nucleotides 69,421 to 69,917 of KSHV genome was used as a probe.
Hybridization was carried out in 6× SSC (1× SSC is 0.15 M NaCl plus
0.015 M sodium citrate), 5× Denhard's solution, 0.5% SDS, and 100 μg
of salmon DNA per milliliter at 60 °C overnight. Membranes were
washed in 2× SSC–0.5% SDS once for 10 min and in 0.1× SSC–0.5% SDS
three times for 25 min at 60 °C.
Acknowledgments
This work was supported by grants CA16038 and CA12055 from
NIH to G.M. and by a medical research grant CMRPD650013 from
Chang-GungMemorial Hospital (Taiwan) and by a grant NSC95-2320-
B-182-054-MY3 from National Science Council (Taiwan) to P.-J.C. We
thank Dr. Tasuku Honjo (Kyoto University) for mouse RBP-Jκ−/−
(OT11) and wild-type (OT13) embryonic ﬁbroblast cells. We thank
Jianjiang Ye for critical reviews of the manuscript and helpful
discussions.
References
Ashburn, C.V., Gray, W.L., 2002. Expression of the simian varicella virus glycoprotein L
and H. Arch. Virol. 147 (2), 335–348.
Boshoff, C., Schulz, T.F., Kennedy, M.M., Graham, A.K., Fisher, C., Thomas, A., McGee, J.O.,
Weiss, R.A., O'Leary, J.J., 1995. Kaposi's sarcoma-associated herpesvirus infects
endothelial and spindle cells. Nat. Med. 1 (12), 1274–1278.
Carroll, K.D., Bu, W., Palmeri, D., Spadavecchia, S., Lynch, S.J., Marras, S.A., Tyagi, S.,
Lukac, D.M., 2006. Kaposi's Sarcoma-associated herpesvirus lytic switch protein
stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway. J. Virol. 80
(19), 9697–9709.
Cesarman, E., Chang, Y., Moore, P.S., Said, J.W., Knowles, D.M., 1995. Kaposi's sarcoma-
associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based
lymphomas. N. Engl. J. Med. 332 (18), 1186–1191.
Chang, P.J., Miller, G., 2004. Autoregulation of DNA binding and protein stability of
Kaposi's sarcoma-associated herpesvirus ORF50 protein. J. Virol. 78 (19),
10657–10673.
Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M., Moore, P.S.,
1994. Identiﬁcation of herpesvirus-like DNA sequences in AIDS-associated Kaposi's
sarcoma. Science 266 (5192), 1865–1869.
Chang, P.J., Shedd, D., Gradoville, L., Cho, M.S., Chen, L.W., Chang, J., Miller, G., 2002.
Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus
directly activates the viral PAN and K12 genes by binding to related response
elements. J. Virol. 76 (7), 3168–3178.
Chang, P.J., Shedd, D., Miller, G., 2005. Two subclasses of Kaposi's sarcoma-
associated herpesvirus lytic cycle promoters distinguished by open reading
frame 50 mutant proteins that are deﬁcient in binding to DNA. J. Virol. 79 (14),
8750–8763.
Chang, P.J., Shedd, D., Miller, G., 2008. A mobile functional region of Kaposi's sarcoma-
associated herpesvirus ORF50 protein independently regulates DNA binding and
protein abundance. J. Virol. 82 (19), 9700–9716.
Chen, J., Ueda, K., Sakakibara, S., Okuno, T., Yamanishi, K., 2000. Transcriptional
regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon
regulatory factor gene. J. Virol. 74 (18), 8623–8634.
48 P.-J. Chang et al. / Virology 398 (2010) 38–48Damania, B., Jeong, J.H., Bowser, B.S., DeWire, S.M., Staudt, M.R., Dittmer, D.P., 2004.
Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesviruses.
J. Virol. 78 (10), 5491–5499.
Dean, H.J., Cheung, A.K., 1993. A 3′ coterminal gene cluster in pseudorabies virus
contains herpes simplex virus UL1, UL2, and UL3 gene homologs and a unique
UL3.5 open reading frame. J. Virol. 67 (10), 5955–5961.
Deng, H., Song, M.J., Chu, J.T., Sun, R., 2002. Transcriptional regulation of the interleukin-
6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J. Virol.
76 (16), 8252–8264.
Deng, H., Young, A., Sun, R., 2000. Auto-activation of the rta gene of human
herpesvirus-8/Kaposi's sarcoma-associated herpesvirus. J. Gen. Virol. 81 (Pt 12),
3043–3048.
Gradoville, L., Gerlach, J., Grogan, E., Shedd, D., Nikiforow, S., Metroka, C., Miller, G.,
2000. Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein
activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell
line. J. Virol. 74 (13), 6207–6212.
Haque, M., Chen, J., Ueda, K., Mori, Y., Nakano, K., Hirata, Y., Kanamori, S., Uchiyama, Y.,
Inagi, R., Okuno, T., Yamanishi, K., 2000. Identiﬁcation and analysis of the K5 gene of
Kaposi's sarcoma-associated herpesvirus. J. Virol. 74 (6), 2867–2875.
Jeong, J., Papin, J., Dittmer, D., 2001. Differential regulation of the overlapping Kaposi's
sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters. J. Virol.
75 (4), 1798–1807.
Kato, H., Taniguchi, Y., Kurooka, H., Minoguchi, S., Sakai, T., Nomura-Okazaki, S., Tamura,
K., Honjo, T., 1997. Involvement of RBP-J in biological functions of mouse Notch1
and its derivatives. Development 124 (20), 4133–4141.
Lai, E.C., 2002. Keeping a good pathway down: transcriptional repression of Notch
pathway target genes by CSL proteins. EMBO Rep. 3 (9), 840–845.
Liang, Y., Ganem, D., 2003. Lytic but not latent infection by Kaposi's sarcoma-associated
herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc. Natl.
Acad. Sci. U.S.A. 100 (14), 8490–8495.
Liang, Y., Ganem, D., 2004. RBP-J (CSL) is essential for activation of the K14/vGPCR
promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein
RTA. J. Virol. 78 (13), 6818–6826.
Liang, Y., Chang, J., Lynch, S.J., Lukac, D.M., Ganem, D., 2002. The lytic switch protein of
KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL),
the target of the Notch signaling pathway. Genes Dev. 16 (15), 1977–1989.
Liao, W., Tang, Y., Kuo, Y.L., Liu, B.Y., Xu, C.J., Giam, C.Z., 2003. Kaposi's sarcoma-
associated herpesvirus/human herpesvirus 8 transcriptional activator Rta is an
oligomeric DNA-binding protein that interacts with tandem arrays of phased A/T-
trinucleotide motifs. J. Virol. 77 (17), 9399–9411.
Liu, Y., Cao, Y., Liang, D., Gao, Y., Xia, T., Robertson, E.S., Lan, K., 2008. Kaposi's sarcoma-
associated herpesvirus RTA activates the processivity factor ORF59 through
interaction with RBP-Jkappa and a cis-acting RTA responsive element. Virology
380 (2), 264–275.
Lukac, D.M., Renne, R., Kirshner, J.R., Ganem, D., 1998. Reactivation of Kaposi's sarcoma-
associated herpesvirus infection from latency by expression of the ORF 50
transactivator, a homolog of the EBV R protein. Virology 252 (2), 304–312.
Lukac, D.M., Kirshner, J.R., Ganem, D., 1999. Transcriptional activation by the product of
open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for
lytic viral reactivation in B cells. J. Virol. 73 (11), 9348–9361.
Lukac, D.M., Garibyan, L., Kirshner, J.R., Palmeri, D., Ganem, D., 2001. DNA binding by
Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for
transcriptional activation of two viral delayed early promoters. J. Virol. 75 (15),
6786–6799.
Miller, G., Heston, L., Grogan, E., Gradoville, L., Rigsby, M., Sun, R., Shedd, D., Kushnaryov,
V.M., Grossberg, S., Chang, Y., 1997. Selective switch between latency and lytic
replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually
infected body cavity lymphoma cells. J. Virol. 71 (1), 314–324.Papugani, A., Coleman, T., Jones, C., Zhang, L., 2008. The interaction between KSHV RTA
and cellular RBP-Jkappa and their subsequent DNA binding are not sufﬁcient for
activation of RBP-Jkappa. Virus Res. 131 (1), 1–7.
Rajcani, J., Andrea, V., Ingeborg, R., 2004. Peculiarities of herpes simplex virus (HSV)
transcription: an overview. Virus Genes 28 (3), 293–310.
Renne, R., Zhong, W., Herndier, B., McGrath, M., Abbey, N., Kedes, D., Ganem, D., 1996.
Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in
culture. Nat. Med. 2 (3), 342–346.
Russo, J.J., Bohenzky, R.A., Chien, M.C., Chen, J., Yan, M., Maddalena, D., Parry, J.P.,
Peruzzi, D., Edelman, I.S., Chang, Y., Moore, P.S., 1996. Nucleotide sequence of the
Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U.S.A. 93 (25),
14862–14867.
Serio, T.R., Kolman, J.L., Miller, G., 1997. Late gene expression from the Epstein-Barr
virus BcLF1 and BFRF3 promoters does not require DNA replication in cis. J. Virol. 71
(11), 8726–8734.
Singh, J., Wagner, E.K., 1993. Transcriptional analysis of the herpes simplex virus type 1
region containing the TRL/UL junction. Virology 196 (1), 220–231.
Song, M.J., Brown, H.J., Wu, T.T., Sun, R., 2001. Transcription activation of polyadeny-
lated nuclear RNA by rta in human herpesvirus 8/Kaposi's sarcoma-associated
herpesvirus. J. Virol. 75 (7), 3129–3140.
Song, M.J., Li, X., Brown, H.J., Sun, R., 2002. Characterization of interactions between RTA
and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated
herpesvirus/human herpesvirus 8. J. Virol. 76 (10), 5000–5013.
Song, M.J., Deng, H., Sun, R., 2003. Comparative study of regulation of RTA-responsive
genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 77
(17), 9451–9462.
Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay,
M.F., Clauvel, J.P., Raphael, M., Degos, L., et al., 1995. Kaposi's sarcoma-associated
herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86 (4),
1276–1280.
Sun, R., Lin, S.F., Gradoville, L., Yuan, Y., Zhu, F., Miller, G., 1998. A viral gene that
activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc.
Natl. Acad. Sci. U.S.A. 95 (18), 10866–10871.
Sun, R., Lin, S.F., Staskus, K., Gradoville, L., Grogan, E., Haase, A., Miller, G., 1999. Kinetics
of Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol. 73 (3),
2232–2242.
Tun, T., Hamaguchi, Y., Matsunami, N., Furukawa, T., Honjo, T., Kawaichi, M., 1994.
Recognition sequence of a highly conserved DNA binding protein RBP-J kappa.
Nucleic Acids Res. 22 (6), 965–971.
Ueda, K., Ishikawa, K., Nishimura, K., Sakakibara, S., Do, E., Yamanishi, K., 2002. Kaposi's
sarcoma-associated herpesvirus (human herpesvirus 8) replication and transcrip-
tion factor activates the K9 (vIRF) gene through two distinct cis elements by a non-
DNA-binding mechanism. J. Virol. 76 (23), 12044–12054.
Wang, Y., Yuan, Y., 2007. Essential role of RBP-Jkappa in activation of the K8 delayed-
early promoter of Kaposi's sarcoma-associated herpesvirus by ORF50/RTA.
Virology 359 (1), 19–27.
Wang, S., Liu, S., Wu, M., Geng, Y., Wood, C., 2001. Kaposi's sarcoma-associated
herpesvirus/human herpesvirus-8 ORF50 gene product contains a potent
C-terminal activation domain which activates gene expression via a speciﬁc target
sequence. Arch. Virol. 146 (7), 1415–1426.
Zhang, L., Chiu, J., Lin, J.C., 1998. Activation of human herpesvirus 8 (HHV-8) thymidine
kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent.
DNA Cell Biol. 17 (9), 735–742.
Zhu, F.X., Cusano, T., Yuan, Y., 1999. Identiﬁcation of the immediate-early transcripts of
Kaposi's sarcoma-associated herpesvirus. J. Virol. 73 (7), 5556–5567.
Ziegelbauer, J., Grundhoff, A., Ganem, D., 2006. Exploring the DNA binding interactions
of the Kaposi's sarcoma-associated herpesvirus lytic switch protein by selective
ampliﬁcation of bound sequences in vitro. J. Virol. 80 (6), 2958–2967.
